What is CalAmp's accrued expenses and other liabilities?

CalAmp (CAMP) reported accrued expenses and other liabilities of -$1.37M in Q1 2026.

How has CalAmp's accrued expenses and other liabilities changed year-over-year?

CalAmp's accrued expenses and other liabilities increased by 50.9% year-over-year, from -$2.79M to -$1.37M.

CalAmp CAMP Accrued expenses and other liabilities

Accrued expenses and other liabilities at other companies

Rapport Therapeutics, Inc.RAPP

——

Sarepta Therapeutics, Inc.SRPT

——

Septerna, Inc.SEPN

——

Other financials

Income statement

See full

Revenue$1.3M+50.8%

Operating income-$13.1M+0.2%

Net income-$18.3M-47.4%

EPS (diluted)-$0.32+48.4%

Balance sheet

See full

Cash & equivalents$100.8M+97.9%

Total debt$2.1M-73.2%

Total equity$30.9M-40.1%

Total assets$105.5M+68.0%

Cash flow

See full

Operating cash flow-$11.0M+23.1%

CapEx--100%

Free cash flow-$11.0M+24.6%

Valuation

See full

Market cap$226.92M+666%

Enterprise value$128.2M-3,860%

P/S57.7×+47.8×

Profitability

See full

Operating margin-1,335.2%-512pp

Net margin-2,193.7%-581pp

FCF margin-1,254%—

Returns & leverage

See full

Return on equity-209.3%—

Debt / equity0.1×-0.1×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by CalAmp in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's accrued expenses and other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CalAmp's accrued expenses and other liabilities?: CalAmp (CAMP) reported accrued expenses and other liabilities of -$1.37M in Q1 2026.
How has CalAmp's accrued expenses and other liabilities changed year-over-year?: CalAmp's accrued expenses and other liabilities increased by 50.9% year-over-year, from -$2.79M to -$1.37M.